Copyright
©The Author(s) 2022.
World J Gastroenterol. Jul 14, 2022; 28(26): 3116-3131
Published online Jul 14, 2022. doi: 10.3748/wjg.v28.i26.3116
Published online Jul 14, 2022. doi: 10.3748/wjg.v28.i26.3116
Figure 10 The evolution of the hepatocellular carcinoma stereotactic body radiation therapy treatment zone in patient shown in Figures 8 and 9.
A: Hepatobiliary phase (HBP) magnetic resonance imaging (MRI) prior to stereotactic body radiation therapy (SBRT); B: SBRT plan with isodose curve distributions; C: HBP MRI 4 mo after treatment; D: HBP MRI 8 mo after treatment; E: HBP MRI 20 mo after treatment. The MRIs demonstrated the progressive fibrotic evolution of the treatment area.
- Citation: Gatti M, Maino C, Darvizeh F, Serafini A, Tricarico E, Guarneri A, Inchingolo R, Ippolito D, Ricardi U, Fonio P, Faletti R. Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment. World J Gastroenterol 2022; 28(26): 3116-3131
- URL: https://www.wjgnet.com/1007-9327/full/v28/i26/3116.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i26.3116